Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021

Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021 | Authorea try { document.documentElement.classList.add('js'); } catch (e) { } var _gaq = _gaq || []; _gaq.push(['_setAccount', 'G-8VDV14Y67G']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); Skip to main content Preprints Collections Wiley Open Research IET Open Research Ecological Society of Japan All Collections About About Authorea FAQs Contact Us Quick Search anywhere Search for preprint articles, keywords, etc. Search Search ADVANCED SEARCH SCROLL This is a preprint and has not been peer reviewed. Data may be preliminary. 16 January 2025 V1 Latest version Share on Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021 Authors : Sharvari Kate Bhosale , Gampa Sarjanya 0009-0006-7067-4838 [email protected] , Abhijit Tilak , and Suresh Dange Authors Info & Affiliations https://doi.org/10.22541/au.173702182.27071991/v1 221 views 118 downloads Contents Abstract Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract Comments on the article entitled Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021, published on 09 July 2024 To, The Editor, British Journal of Clinical Pharmacology Subject: Letter to editor Dear Sir, We read with interest the article entitled-Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021, published in your esteemed journal.[1] We congratulate the authors for a well conducted study. However, we have few comments. The authors have found marked increase in the prevalence of antidepressant and antipsychotic prescribing in patients with T2D in Scotland. Neil Drummond et al have reported in 2018 that a substantial number of patients with dementia were prescribed antidepressant or antipsychotic medications by their primary care practitioners. There was no evidence of depression or psychosis in their electronic medical records.[2] Similarly, Siddhartha Ghosh and Sugata Roychaudhury observed that in India, 10% of the patients were prescribed a combination of two antidepressants. 14.18% of the patients were co-prescribed antipsychotics for the treatment of their psychotic symptoms.[3] Greene CRL et al have also reviewed the prescribing of antidepressant and antipsychotic drugs and studied the diabetes outcomes. Antidepressant prescribing may be associated with increased risk of macrovascular disease in this population of patients.[4] Depression is common among diabetic patients and this justifies the use of antidepressants.[5] Thanking you, Dr. Sharvari Kate Bhosale References: 1. Greene CRL. Blackbourn LAK, McGurnaghan SJ et al. Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021. Br J Clin Pharmacol. 2024;90:2802–2810. 2. Neil Drummond et al. Antidepressant and antipsychotic prescribing in primary care for people with dementia. Canadian Family Physician | Le Médecin de famille canadien } Vol 64: NOVEMBER | NOVEMBRE 2018. 3. Siddhartha Ghosh and Sugata Roychaudhury. Prescribing pattern of antidepressant drugs in a tertiary care hospital of eastern India J. Chem. Pharm. Res., 2014, 6(6):2593-2597. 4. Greene CRL et al. Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies. Diabetes Research and Clinical Practice 199 (2023) 110649 5. Kant R, Yadav P, Barnwal S, Dhiman V, Abraham B, Gawande K. Prevalence and predictors of depression in type 2 diabetes mellitus. J Edu Health Promot 2021;10:352. Information & Authors Information Version history V1 Version 1 16 January 2025 Copyright This work is licensed under a Non Exclusive No Reuse License. Keywords antidepressants antipsychotics diabetes endocrinology psychopharmacology Authors Affiliations Sharvari Kate Bhosale Dr D Y Patil Vidyapeeth (Deemed to be University) View all articles by this author Gampa Sarjanya 0009-0006-7067-4838 [email protected] Dr D Y Patil Vidyapeeth (Deemed to be University) View all articles by this author Abhijit Tilak Dr D Y Patil Vidyapeeth (Deemed to be University) View all articles by this author Suresh Dange Dr D Y Patil Vidyapeeth (Deemed to be University) View all articles by this author Metrics & Citations Metrics Article Usage 221 views 118 downloads .FvxKWukQNSOunydq8rnd { width: 100px; } Citations Download citation Sharvari Kate Bhosale, Gampa Sarjanya, Abhijit Tilak, et al. Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time-trend analysis from 2004 to 2021. Authorea . 16 January 2025. DOI: https://doi.org/10.22541/au.173702182.27071991/v1 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu . Format Please select one from the list RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks Direct import Tips for downloading citations document.getElementById('citMgrHelpLink').addEventListener('click', function() { popupHelp(this.href); return false; }); $(".js__slcInclude").on("change", function(e){ if ($(this).val() == 'refworks') $('#direct').prop("checked", false); $('#direct').prop("disabled", ($(this).val() == 'refworks')); }); View Options View options PDF View PDF Figures Tables Media Share Share Share article link Copy Link Copied! Copying failed. Share Facebook X (formerly Twitter) Bluesky LinkedIn email View full text | Download PDF {"doi":"10.22541/au.173702182.27071991/v1","type":"Article"} Now Reading: Share Figures Tables Close figure viewer Back to article Figure title goes here Change zoom level Go to figure location within the article Download figure Toggle share panel Toggle share panel Share Toggle information panel Toggle information panel Go to previous graphic Go to next graphic Go to previous table Go to next table All figures All tables View all material View all material xrefBack.goTo xrefBack.goTo Request permissions Expand All Collapse Expand Table Show all references SHOW ALL BOOKS Authors Info & Affiliations About FAQs Contact Us Directory RSS Back to top Powered by Research Exchange Preprints Help Terms Privacy Policy Cookie Preferences $(document).ready(() => setTimeout(() => { let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" ")); $.get("/resource/lodash?t="+_bnt); },4000)); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9fea35b8d93c06db',t:'MTc3OTI2ODI0Mw=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();